Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytes
- Conditions
- Palliative care cancer patients starting with opioidsMedDRA version: 9.1Level: LLTClassification code 10010774Term: Constipation
- Registration Number
- EUCTR2007-007610-10-NL
- Lead Sponsor
- MC Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Palliative care cancer patients started on morphine, fentanyl, oxycocodon, hydromorphon, methadone, codeine or tramadol
Age >18 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Patients with a contra-indication for laxatives
Patiens who have used laxatives within four weeks prior to inclusion in the study
Estimated life expectancy <3 months
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method